Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 28 May 2026 for Artiva Biotherapeutics, Inc., €10.6M. Read the official filing
Filing timeline
BuySaleGC Corp.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+50.6%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +50.6%Entry US$7.93 · Close at T+90 US$11.94
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
GC Corp.: trading record in brief
This profile gathers the share dealings of GC Corp. in Artiva Biotherapeutics, Inc. The record holds 3 filings, for trades running from 22 July 2024 to 11 May 2026.
The open-market record is one-sided, with 2 purchases worth €14.0M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 2 purchases and no sales on the market.
The newest entry dates from 28 May 2026: an open-market purchase of €10.6M, in Artiva Biotherapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to GC Corp.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3 of 3 declarations
